Willis Investment Counsel’s MaxCyte MXCT Stock Holding History

Willis Investment Counsel’s Portfolio MXCT Stock Details MXCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.06M	Hold	862,758	–	–	0.05%	97
2026 Q1	$606K	Hold	862,758	–	–	0.03%	100
2025 Q4	$1.34M	Hold	862,758	–	–	0.07%	100
2025 Q3	$1.36M	Buy	862,758 +482,287	+127%	+$838K	0.07%	93
2025 Q2	$829K	Hold	380,471	–	–	0.05%	96
2025 Q1	$1.04M	Sell	380,471 -25,000	-6%	-$98.6K	0.07%	87
2024 Q4	$1.69M	Hold	405,471	–	–	0.11%	77
2024 Q3	$1.58M	Sell	405,471 -33,279	-8%	-$140K	0.1%	76
2024 Q2	$1.72M	Sell	438,750 -86,250	-16%	-$371K	0.12%	74
2024 Q1	$2.2M	Sell	525,000 -25,000	-5%	-$117K	0.15%	75
2023 Q4	$2.58M	Buy	+550,000	New	+$2.14M	0.18%	79

Other funds holding MXCT

CFM

Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return

Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Mudita Advisors London, United Kingdom $481M AUM 73.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BFM

Brooklands Fund Management London, United Kingdom $128M AUM

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

CCM

Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return

PLC

Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

Willis Investment Counsel's MXCT Position: Q2 2026 in Review

Willis Investment Counsel held its MaxCyte (MXCT) position steady in Q2 2026 at 862,758 shares worth $1.06M. The position accounts for 0.05% of the portfolio, ranked #97.

Willis Investment Counsel first reported a position in MXCT in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.58M in Q4 2023. 122 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

Willis Investment Counsel held 862,758 shares of MaxCyte worth $1.06M as of Q2 2026.
Willis Investment Counsel left its MaxCyte share count unchanged in Q2 2026.
MaxCyte made up 0.05% of Willis Investment Counsel's portfolio in Q2 2026, its #97 holding.
Willis Investment Counsel first reported a position in MaxCyte in Q4 2023 and has held it in 11 quarters since.
Willis Investment Counsel's MaxCyte position peaked at $2.58M in Q4 2023.
122 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on Willis Investment Counsel's 13F filing for Q2 2026, filed 3 Aug 2026.